Conversely, the expression of KYNU, AOX1, KMO, TDO2, ACAT1, DDC, CYPIAI, OGDHL, WASRS1, AFMID, CYP1A2, ASMT, and TPH2 was lower in glioma than normal brain tissue samples. This evidence concerns the gene CYP1A2 and central nervous system cancer.